| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.56B | 27.12B | 26.23B | 26.74B | 24.24B | 21.61B |
| Gross Profit | 2.64B | 2.57B | 2.46B | 2.40B | 2.14B | 2.03B |
| EBITDA | 626.99M | 571.15M | 518.05M | 455.72M | 373.35M | 264.17M |
| Net Income | 946.54M | 629.35M | 346.66M | 303.74M | 62.53M | 76.39M |
Balance Sheet | ||||||
| Total Assets | 14.87B | 16.18B | 17.87B | 16.40B | 15.67B | 15.47B |
| Cash, Cash Equivalents and Short-Term Investments | 1.14B | 1.57B | 2.46B | 1.68B | 1.19B | 1.69B |
| Total Debt | 0.00 | 720.34M | 13.69M | 239.12M | 153.81M | 159.91M |
| Total Liabilities | 6.13B | 7.47B | 7.71B | 7.09B | 6.66B | 5.97B |
| Stockholders Equity | 8.73B | 8.71B | 10.16B | 9.31B | 9.00B | 9.49B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -676.85M | 1.13B | 588.30M | -599.70M | 767.22M |
| Operating Cash Flow | 0.00 | -666.35M | 1.19B | 607.67M | -502.11M | 925.14M |
| Investing Cash Flow | 0.00 | 846.89M | -206.78M | -151.79M | 131.22M | -202.60M |
| Financing Cash Flow | 0.00 | -1.22B | -147.11M | -82.48M | -144.31M | -200.07M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥4.00B | 8.10 | ― | 2.24% | 4.29% | 240.24% | |
76 Outperform | ¥79.56B | 6.04 | ― | 3.04% | 1.57% | -33.97% | |
75 Outperform | ¥49.76B | 8.18 | ― | 5.04% | -3.21% | 27.18% | |
74 Outperform | ¥36.35B | 15.61 | ― | 3.70% | 14.83% | 51.42% | |
69 Neutral | ¥2.32T | 13.66 | 11.64% | 1.52% | 9.81% | 32.64% | |
68 Neutral | ¥408.31B | 7.90 | 13.71% | 3.38% | 0.29% | 27.84% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |